Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna gains full FDA approval for COVID-19 vaccine while Novavax makes push for its own shot

WASHINGTON — Moderna Inc.’s vaccine for COVID-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.

Tribune News Service

Why Moderna Shares Are Rising Today

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

Benzinga

Moderna's COVID-19 Vaccine Becomes Second To Score Complete FDA Approval

The FDA has given complete approval to Moderna Inc's (NASDAQ:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA fully approves Moderna's COVID vaccine

Moderna's vaccine will now be marketed as Spikevax.

Axios

Moderna announces full US approval for its COVID-19 vaccine

Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness

The Independent UK

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Benzinga

Covid news: UK health secretary says mandatory vaccination for NHS workers ‘no longer proportionate’ – as it happened

Sajid Javid says says mandatory jabs were ‘right policy at the time’ but announces review

The Guardian - AU

Read news from The Economist, FT, and more,
with one subscription

An HIV vaccine is finally on its way

The same mRNA technology that’s helping us fight COVID provided a formula that’s evaded scientists for 40 years.

Mic

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically

Benzinga

Moderna Begins Trial of Omicron-specific Vaccine Booster

US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.

Asharq Al-Awsat

Boosters increase protection against death from Omicron in over-50s to 95% – UKHSA; UK records 338 deaths – as it happened

Protection against death increases to around 95% two weeks after receiving a booster dose, UK health agency says; UK reports another 96,871 Covid cases

The Guardian - UK

Moderna begins testing omicron-matched COVID shots in adults

Moderna has begun testing an omicron-specific version of its COVID-19 vaccine in healthy adults

The Independent UK

Why Moderna Shares Are Rising

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Down Close to 40% Year-To-Date, Now is a Good Time to Scoop Up Moderna and BioNTech

The ongoing market correction has caused the shares of popular vaccine makers Moderna (MRNA) and BioNTech (BNTX) to decline nearly 40% in price so far this year. However, because the demand for COVID-19 vaccines remains strong globally, these companies are expected to generate substantial revenues and profits in the coming…

The Guardian - AU

UK reports 346 daily deaths; Denmark aims to end all restrictions – as it happened

UK also records over 102,000 daily cases; Danish plan would mean most far-reaching easing among Nordic countries

Daily Record

NHS Lanarkshire now administering Moderna jab as part of vaccination programme

The health board confirmed the plans as the booster programmes continues across Lanarkshire.

Benzinga

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

5 Stocks Insiders Are Selling: Alphabet, Moderna And More

Crude oil futures dipped more than 2% on Monday as the US dollar strengthened following increasing concerns between the US and Russia over Ukraine. Investors, meanwhile, focused on some notable insider trades.

The Conversation

How mRNA and DNA vaccines could soon treat cancers, HIV, autoimmune disorders and genetic diseases

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines.…

The Times of India

Booster shots are instrumental in fighting Omicron, CDC data show

Booster shots of the Pfizer-BioNTech and Moderna vaccines are not just preventing infections with the contagious omicron variant — they are also keeping infected Americans from ending up in the hospital, according to data published Friday by the Centers for Disease Control and Prevention.

Benzinga

Moderna Whale Trades For January 21

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022

Asharq Al-Awsat

Hajj, Umrah Ministry Exempts Immunized with Approved Vaccines from Quarantine

Saudi Arabia’s Ministry of Hajj and Umrah has decided that travelers inbound to the Kingdom who have received a full dose of one of the approved vaccines, including Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, Moderna, are exempt from the need to quarantine. In a statement to Asharq Al-Awsat, the Ministry revealed…

Benzinga

This Storage Unit Stock Has A Better 1-Year Return Than Microsoft, Apple, Starbucks And Moderna

Public Storage (NYSE: PSA) helps organize and store your belongings, and over the past year delivered astonishing returns.

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.